A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.


Updates from The Motley Fool

Latest updates on Alexion Pharmaceuticals from Fool.com.


Stock Performance

ALXN vs. S&P 500 | 2 Year Performance
View Interactive ALXN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Alexion Pharmaceuticals.
Current Price: $138.01
Prev Close: $137.42
Open: $137.07
Bid: $137.75
Ask: $137.90
Day's Range: $136.69 - $138.25
52wk Range: $110.56 - $193.45
Volume: 420,530
Avg Vol 1,507,789
Market Cap: $31.10B
P/E (ttm): 458.07
EPS (ttm): $0.30
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Alexion Pharmaceuticals.
CAPS Rating 3 out of 5
 
308 Outperform
55 Underperform
CAPS All Stars
 
76 Outperform
8 Underperform

How do you think Alexion Pharmaceuticals will perform against the market?



You pick for Alexion Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Alexion Pharmaceuticals.

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers